Ignite Creation Date:
2025-12-24 @ 12:12 PM
Ignite Modification Date:
2026-05-30 @ 2:34 PM
Study NCT ID:
NCT04468061
Status:
RECRUITING
Last Update Posted:
2025-12-05
First Post:
2020-07-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
Sponsor:
Organization: